CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma

被引：0
|
作者：
Young Chang
Yun Bin Lee
Eun Ju Cho
Jeong-Hoon Lee
Su Jong Yu
Yoon Jun Kim
Jung-Hwan Yoon
机构：
[1] Department of Internal Medicine and Liver Research Institute,Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine
[2] Seoul National University College of Medicine,undefined
[3] Soonchunhyang University College of Medicine,undefined
来源：
BMC Cancer | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma
    Chang, Young
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    BMC CANCER, 2020, 20 (01)
  • [2] CKD5, a Novel Pan-Histone Deacetylase Inhibitor, Synergistically Enhances the Efficacy of Sorafenib for Hepatocellular Carcinoma
    Chang, Young
    Kang, Seong Hee
    Cho, Eun Ju
    Lee, Hyo-Young
    Yoon, Jun Sik
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan, Sr.
    HEPATOLOGY, 2018, 68 : 1258A - 1258A
  • [3] Potent preclinical antitumor effects induced by pan-histone deacetylase inhibitor panobinostat in combination with sorafenib in hepatocellular carcinoma
    Toffanin, Sara
    Lachenmayer, Anja
    Alsinet, Clara
    Cabellos, Laia
    Minguez, Beatriz
    Tsai, Hung-Wen
    Hoshida, Yujin
    Villanueva, Augusto
    Ward, Stephen C.
    Thung, Swan
    Friedman, Scott L.
    Llovet, Josep M.
    CANCER RESEARCH, 2012, 72
  • [4] Preclinical Efficacy and Toxicity Analysis of the Pan-Histone Deacetylase Inhibitor Gossypol for the Therapy of Colorectal Cancer or Hepatocellular Carcinoma
    Mayer, Mascha
    Berger, Alexander
    Leischner, Christian
    Renner, Olga
    Burkard, Markus
    Boecker, Alexander
    Noor, Seema
    Weiland, Timo
    Weiss, Thomas S.
    Busch, Christian
    Lauer, Ulrich M.
    Bischoff, Stephan C.
    Venturelli, Sascha
    PHARMACEUTICALS, 2022, 15 (04)
  • [5] Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
    Lu, Yen-Shen
    Kashida, Yoko
    Kulp, Samuel K.
    Wang, Yu-Chieh
    Wang, Dasheng
    Hung, Jui-Hsiang
    Tang, Monica
    Lin, Zhong-Zhe
    Chen, Jung
    Cheng, Ann-Lii
    Chen, Ching-Shih
    HEPATOLOGY, 2007, 46 (04) : 1119 - 1130
  • [6] CKD-581, a novel histone deacetylase inhibitor, synergistically enhances Bortezomib cytotoxicity in multiple myeloma cells
    Lee, Chansu
    Ahn, Kwang-Sung
    Jung, Woo June
    Koh, Youngil
    Kim, Hyo Jung
    Lee, Hyun Jung
    Yoon, Hwi-Joong
    Yoon, Sung-Soo
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Protein Disulfide Isomerase Inhibition Synergistically Enhances the Efficacy of Sorafenib for Hepatocellular Carcinoma
    Won, Jae-Kyung
    Yu, Su Jong
    Hwang, Chae Young
    Cho, Sung-Hwan
    Park, Sang-Min
    Kim, Kwangsoo
    Choi, Won-Mook
    Cho, Hyeki
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Lee, Kyung Bun
    Kim, Yoon Jun
    Suh, Kyung-Suk
    Jang, Ja-June
    Kim, Chung Yong
    Yoon, Jung-Hwan
    Cho, Kwang-Hyun
    HEPATOLOGY, 2017, 66 (03) : 855 - 868
  • [8] DICKKOPF-1 INHIBITOR SYNERGISTICALLY ENHANCES THE ANTITUMOR ACTIVITY OF SORAFENIB IN HEPATOCELLULAR CARCINOMA
    Seo, Sang Hyun
    HEPATOLOGY, 2022, 76 : S1251 - S1252
  • [9] A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma
    Zhang, Kai
    Wang, Ting
    Zhou, Hao
    Feng, Bing
    Chen, Ying
    Zhi, Yingru
    Wang, Rui
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 13 : 176 - 188
  • [10] The histone deacetylase inhibitor SB939 acts synergistically with Sorafenib in an orthotopic model of hepatucellular carcinoma
    Novotny-Diermayr, Veronica
    Sangthongpitag, Kanda
    Goh, Miah Kiat
    Loh, Yung Kiang
    Ong, Lai Chun
    Pasha, Mohammed K.
    Jayaraman, Ramesh
    Ethirajulu, Kantharaj
    Wood, Jeanette M.
    CANCER RESEARCH, 2010, 70
12345